Veracyte, Inc.
Symbol: VCYT (NASDAQ)
32.29
▼ (-5.94%) -2.040
Company Description:
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.
Key Stats
- Today's Open: $33.99
- Today's High: $33.99
- Today's Low: $32.29
- Today's Volume: 104
- Yesterday Close: $34.33
- Yesterday High: $34.77
- Yesterday Low: $33.22
- Yesterday Volume: 1.02M
- Last Min Volume: 1
- Last Min High: $32.29
- Last Min Low: $32.29
- Last Min VWAP: $32.29
Company Profile
- Name: Veracyte, Inc.
- Website: https://www.veracyte.com
- Listed Date: 2013-10-30
- Location: SOUTH SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001384101
- SIC Code: 8071
- SIC description: SERVICES-MEDICAL LABORATORIES
- Market Cap: $2.70B
- Round Lot: 100
- Outstanding Shares: 78.67M
- Asset Type: CS
RECENT FILINGS FOR VCYT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-23 | 4 | View |
| 2025-09-19 | 144 | View |
| 2025-09-08 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 144 | View |
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-08-01 | SCHEDULE 13G/A | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
Latest News on VCYT